Dawling S - Search Results

1

Unmasked adult-onset urea cycle disorders in the critical care setting.

Summar ML, Barr F, Dawling S, Smith W, Lee B, Singh RH, Rhead WJ, Sniderman King L, Christman BW. Summar ML, et al. Among authors: dawling s. Crit Care Clin. 2005 Oct;21(4 Suppl):S1-8. doi: 10.1016/j.ccc.2005.05.002. Crit Care Clin. 2005. PMID: 16227111 Review.

2

Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function.

Pearson DL, Dawling S, Walsh WF, Haines JL, Christman BW, Bazyk A, Scott N, Summar ML. Pearson DL, et al. Among authors: dawling s. N Engl J Med. 2001 Jun 14;344(24):1832-8. doi: 10.1056/NEJM200106143442404. N Engl J Med. 2001. PMID: 11407344 Free article.

3

Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.

Crooke PS, Justenhoven C, Brauch H; GENICA Consortium; Dawling S, Roodi N, Higginbotham KS, Plummer WD, Schuyler PA, Sanders ME, Page DL, Smith JR, Dupont WD, Parl FF. Crooke PS, et al. Among authors: dawling s. Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1502-15. doi: 10.1158/1055-9965.EPI-11-0060. Epub 2011 May 24. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21610218 Free PMC article.

4

Estrogen metabolism and breast cancer: a risk model.

Parl FF, Dawling S, Roodi N, Crooke PS. Parl FF, et al. Among authors: dawling s. Ann N Y Acad Sci. 2009 Feb;1155:68-75. doi: 10.1111/j.1749-6632.2008.03676.x. Ann N Y Acad Sci. 2009. PMID: 19250193 Free PMC article. Review.

5

Estrogens, enzyme variants, and breast cancer: a risk model.

Crooke PS, Ritchie MD, Hachey DL, Dawling S, Roodi N, Parl FF. Crooke PS, et al. Among authors: dawling s. Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1620-9. doi: 10.1158/1055-9965.EPI-06-0198. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16985022

6

Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

Dawling S, Roodi N, Mernaugh RL, Wang X, Parl FF. Dawling S, et al. Cancer Res. 2001 Sep 15;61(18):6716-22. Cancer Res. 2001. PMID: 11559542

7

Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.

Hanna IH, Dawling S, Roodi N, Guengerich FP, Parl FF. Hanna IH, et al. Among authors: dawling s. Cancer Res. 2000 Jul 1;60(13):3440-4. Cancer Res. 2000. PMID: 10910054

8

In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.

Dawling S, Hachey DL, Roodi N, Parl FF. Dawling S, et al. Chem Res Toxicol. 2004 Sep;17(9):1258-64. doi: 10.1021/tx0498657. Chem Res Toxicol. 2004. PMID: 15377160

9

Resolution of an apparent hook effect in Roche partner DRI oxycodone immunoassay.

Colón-Franco JM, Cox ET, Crosby DB, Dawling S. Colón-Franco JM, et al. Among authors: dawling s. J Anal Toxicol. 2013 Jul-Aug;37(6):376-81. doi: 10.1093/jat/bkt044. Epub 2013 May 27. J Anal Toxicol. 2013. PMID: 23711948

10

Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.

Dawling S, Roodi N, Parl FF. Dawling S, et al. Cancer Res. 2003 Jun 15;63(12):3127-32. Cancer Res. 2003. PMID: 12810639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters